Bio Genex Surgicals India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-12-2024
- Paid Up Capital ₹ 0.50 M
as on 09-12-2024
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -43.70%
(FY 2021)
- Profit 74.25%
(FY 2021)
- Ebitda 15.98%
(FY 2021)
- Net Worth 3.74%
(FY 2021)
- Total Assets 2.29%
(FY 2021)
About Bio Genex Surgicals India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Neelam Gupta, Mukesh Gupta, and Saurabh Gupta serve as directors at the Company.
- CIN/LLPIN
U24123HP1994PTC031701
- Company No.
031701
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bio Genex Surgicals India Pvt Ltd offer?
Bio Genex Surgicals India Pvt Ltd offers a wide range of products and services, including Plastic & Glass Labware, Laboratory Plasticware.
Who are the key members and board of directors at Bio Genex Surgicals India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Gupta  | Director | 10-Oct-2011 | Current |
| Neelam Gupta | Director | 23-Sep-1996 | Current |
| Mukesh Gupta | Director | 09-Nov-1994 | Current |
Financial Performance of Bio Genex Surgicals India.
Bio Genex Surgicals India Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 43.7% decrease. The company also saw a substantial improvement in profitability, with a 74.25% increase in profit. The company's net worth moved up by a moderate rise of 3.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Genex Surgicals India?
In 2021, Bio Genex Surgicals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genaxy Scientific Private LimitedActive 25 years 11 monthsMukesh Gupta and Saurabh Gupta are mutual person
Genaxy Bioinnovations Private LimitedActive 10 monthsMukesh Gupta and Saurabh Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio Genex Surgicals India?
Unlock and access historical data on people associated with Bio Genex Surgicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Genex Surgicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Genex Surgicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
